Current Report Filing (8-k)
May 01 2018 - 7:41AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of Report (Date of earliest event reported)
May 1, 2018
KRAIG BIOCRAFT LABORATORIES, INC.
(Exact
name of registrant as specified in its charter)
Wyoming
|
|
83-0459707
|
(State
or other jurisdiction of incorporation or
organization)
|
|
(I.R.S.
Employer Identification No.)
|
|
|
|
2723 South State St. Suite 150
Ann Arbor, Michigan
|
|
48104
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
(734) 619-8066
(Registrant’s
telephone number, including area code)
(Former
name or former address, if changed since last report)
Copies to:
Hunter
Taubman Fischer LLC
1450
Broadway, 26
th
Floor
New
York, NY 10018
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[
] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[
] Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
[
] Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[
] Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 – Other Events
On May
1, 2018, the Company issued a press release, attached as Exhibit
99.1 hereto, regarding the Company’s receipt of an Enterprise
Registration Certificate which will allow the Company to begin its
operations in Vietnam.
Copies
of the press release shall not be considered as an offer to sell or
a solicitation of an offer to buy any securities of the Company in
any jurisdiction where the offer or sale is not permitted. In
addition, such materials shall not be deemed to be
“filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, nor shall they be deemed incorporated by
reference in any filing under the Securities Act of 1933, except as
shall be expressly set forth by specific reference in such
filing.
Item 9.01 Financial Statements and Exhibits
(a)—(c) Not
applicable.
(d)
Exhibits
Exhibit
|
|
Description
|
99.1
|
|
Press
Release
|
|
|
|
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the Registrant
has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
Kraig Biocraft Laboratories, Inc.
|
|
|
|
Date:
May 1, 2018
|
By:
|
/s/ Kim Thompson
|
|
|
Kim
Thompson,
Chief
Executive Officer
|
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Apr 2023 to Apr 2024